Anixa Biosciences, Inc. (ANIX) financial statements and ratios from SEC XBRL: revenue $210000.00 (TTM), net margin -5978.1%, revenue growth -100.0% YoY. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $210000.00 |
| Net Margin | -5978.1% |
| Revenue Growth (YoY) | -100.0% |
| EPS Growth (YoY) | 21.9% |
| FCF Growth (YoY) | 18.1% |
| Price / Book | 9.53 |
| Sector P/E (Healthcare) | 21.7 |
ANIX overview · ANIX earnings · ANIX KPIs · ANIX investor relations · ANIX ownership · ANIX peers · ANIX filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.